Generic drugs news from FiercePharma
News
Generics makers face Chinese threat
In an interesting twist on the usual generics news, it's the copycat makers who are predicted to suffer as competitors undercut their products. The source of this competition? None other than China, Read more...
Study: Costlier drug worked better
Here's some rock-and-a-hard-place news about drug costs. Drug makers raised prices by an average of 7.4 percent on the brand-name meds Read more...
ALSO NOTED: Medtronic earnings drop 89%; GSK buys back 2.7M shares;
> Medtronic's third-quarter earnings plummeted by 89 percent to $77 million because of charges on lawsuit settlements and acquisition costs, but even the adjusted profit beat Wall Street Read more...
Novartis CEO's pay drops with profits
Novartis had a tough year in 2007: Its vaunted new diabetes drug Galvus got the stiff-arm treatment from Read more...
Wanted: Rugged pharmas for tough trip
Batten down the hatches. The voyage ahead is one of Odyssean proportions, with generic drugs ready to suck away sales like the Charybdis maelstrom and biotech bewitching R&D like the Read more...
Op-Ed: Generics aren't always equal
Now here's an op-ed Big Pharma can unite behind. In the Baltimore Sun, journalist and patient Naomi Wax assails the FDA for calling generic drugs exactly equivalent to their brand-name counterparts. Read more...
Mylan CEO intent on new global biz
The rise of generic drugs has been bad news for Big Pharma, but not so bad for copycat makers like Mylan, which gets the profile treatment today from its hometown newspaper, the Pittsburgh Read more...
Drug lobby stalls pro-generics bill
Getting generic drugs to market faster? That's heresy to brand-name Pharma. And it's simple economics: The longer a branded drug can be sold without competition from lower-cost generics, Read more...
Indian firms to sell generic Trileptal
Two Indian pharma companies got the FDA's approval to sell generic forms of the Novartis epilepsy drug Trileptal. Sun Pharma and Glenmark Pharmaceuticals, both based in Mumbai, are OK'd to market the Read more...
Drug-safety hazards many and growing
Oh, the good old days, when all prescription drugs were safe, all vitamins healthful, all over-the-counter meds uncontaminated. Now, a host of hazards plagues the average medicine cabinet--or such is Read more...
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight